This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

About Diabetes » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

New Study Shows Chromium Improves Diabetes and Lipid Control

Posted: Friday, June 22, 2007

Published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).

Slow Release Topiramate Helps Diabetics Lose Weight

Posted: Friday, June 22, 2007

A controlled release formulation of topiramate is effective adjunctive therapy for weight loss in obese type 2 diabetics treated with diet and exercise alone or in combination with metformin, researchers report in the June issue of Diabetes Care.

New Study Shows No Increased Heart Risk With Avandia

Posted: Thursday, June 14, 2007

Findings from an interim analysis of RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycemia in Diabetes), shows further proof the safety of Avandia.

FDA Orders New Safety Labels for Rosiglitazone (Avandia) and Pioglitazone (Actos)

Posted: Thursday, June 14, 2007

The FDA Commissioner Andrew C. von Eschenbach, M.D., told a congressional hearing that the FDA will beef up the cardiovascular warnings on the labels of both rosiglitazone (Avandia) and pioglitazone (Actos).

Researchers Find New Target For Type 2 Diabetes That Reduces Stored Fat

Posted: Thursday, June 14, 2007

Researchers have discovered a potential new target for treating type 2 diabetes, according to a new study that appeared online in Nature. The target is a protein, along with its molecular partner, that regulates fat metabolism.

Once-Weekly Exenatide Formulation Improves Glycemic Control and Body Weight

Posted: Thursday, June 14, 2007

There were no serious adverse events related to exenatide use, the report indicates, and none of the mild to moderate adverse events required discontinuation of exenatide LAR.

Prescriber's Letter Clarifies Avandia Heart Attack Warning With Algorithm

Posted: Friday, June 08, 2007

Analysts at Prescriber's Letter say that crunching the study's numbers reveals only part of the story. Since this report is a meta-analysis, it is merely a study of prior study results.

Resistance to Daily Aspirin Therapy Seen in Diabetics

Posted: Friday, June 01, 2007

Diabetic patients exhibit a higher prevalence of aspirin resistance at a dosage of 81 mg/day than do nondiabetics with coronary artery disease.

Type 2 Diabetes Devastating for Teens

Posted: Friday, June 01, 2007

"The complications associated with adolescents' type 2 diabetes seems to behave differently than in children and adolescents with type 1 diabetes."

These complications may be present at the time of diagnosis, and their rate of progression may be higher than in children and adolescents with type 1 diabetes.

Insulin Making Cells From Umbilical Cord Blood

Posted: Friday, June 01, 2007

Stem cells taken from the umbilical cords of newborns can be engineered to produce insulin and may some day be used to treat diabetes, US and British researchers say.